Contact this trialFirst, we need to learn more about you.
Chemotherapy
Zanubrutinib vs Bendamustine + Rituximab for Chronic Lymphocytic Leukemia
Recruiting2 awardsPhase 3
Tyler, Texas
This trial is comparing the effectiveness of zanubrutinib to a combination of bendamustine and rituximab in patients who have not been treated for CLL/SLL before, as measured by how long they live without the disease progressing.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.